We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Phase 3 Data

News   Mar 28, 2012

 
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Phase 3 Data
 
 
Advertisement
 

RELATED ARTICLES

A Mirror-image Peptide Tumor Treatment

News

Scientists have developed a new approach to immunological tumor treatment. Their method is based on the specific blockade of an immune checkpoint by a stable "mirror-image" peptide.

READ MORE

Next-generation Triple Antibody Test for COVID-19 Given Green Light by MHRA

News

Scientists have developed and received MHRA approval for a new device that could allow health professionals to test patients’ antibody response to COVID-19 in as little as seven minutes.

READ MORE

Light-activated Nanoparticles Inhibit Tumor Growth

News

A unique nanoparticle to deliver a localized cancer treatment inhibits tumor growth in mice, according to new research conducted at Penn State University.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE